The range and extent of inhaled corticosteroid (ICS) side effects experienced by patients in
the general community are likely to be underestimated. AIMS: To identify the side effects of …

This study examined the utilisation patterns of inhaled corticosteroids in England/Wales and
the Netherlands. Computerised medical records from the GPRD (UK) and PHARMO (the …

WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT• Early discontinuation of treatment in
new users of inhaled corticosteroids (ICS) has been widely discussed, but patients' reasons …

The frequent use of inhaled corticosteroids (ICSs), especially at higher doses, has been
accompanied by concern about both systemic and local side effects. The systemic …

The National Asthma Education and Prevention Program 1997 guidelines and 2002 update
provide an overview of potential local and systemic side effects associated with inhaled …

Background Patient-reported side effect questionnaires offer a simple method for the
systematic measurement of drug-related side effects. In order to measure patients' inhaled …

Inhaled corticosteroids (ICS) are the standard of care in asthma and are widely used in the
treatment of patients with chronic obstructive pulmonary disease. High-dose regimens and …

Background Inhaled corticosteroids (ICS) are a prevailing treatment option for COPD
patients but recent guidelines have relegated their use predominantly to patients with …

Introduction: The frequent use of inhaled corticosteroids (ICSs), especially at higher doses,
has been accompanied by concern about both systemic and local side effects. Patients …

Evidence and guidelines are becoming increasingly clear about imbalance between the
risks and benefits of inhaled corticosteroids (ICSs) in patients with COPD. While selected …